BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koola MM. Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyond. Hum Psychopharmacol 2021;36:1-16. [PMID: 32965756 DOI: 10.1002/hup.2758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Bruno JP. Enhancing the resolution of behavioral measures: Key observations during a forty year career in behavioral neuroscience. Neurosci Biobehav Rev 2023;145:105004. [PMID: 36549379 DOI: 10.1016/j.neubiorev.2022.105004] [Reference Citation Analysis]
2 Pastor V, Medina JH. α7 nicotinic acetylcholine receptor in memory processing. Eur J Neurosci 2023. [PMID: 36634032 DOI: 10.1111/ejn.15913] [Reference Citation Analysis]
3 Sapienza J, Spangaro M, Guillemin GJ, Comai S, Bosia M. Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies. Eur Arch Psychiatry Clin Neurosci 2022. [DOI: 10.1007/s00406-022-01519-0] [Reference Citation Analysis]
4 Yang Q, Zhang Y, Yang K, Niu Y, Fan F, Chen S, Luo X, Tan S, Wang Z, Tong J, Yang F, Li CR, Tan Y. Associations of the serum kynurenine pathway metabolites with P50 auditory gating in non-smoking patients with first-episode schizophrenia. Front Psychiatry 2022;13:1036421. [DOI: 10.3389/fpsyt.2022.1036421] [Reference Citation Analysis]
5 Li D, Yu S, Long Y, Shi A, Deng J, Ma Y, Wen J, Li X, Liu S, Zhang Y, Wan J, Li N, Ao R. Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders. Front Immunol 2022;13:985378. [DOI: 10.3389/fimmu.2022.985378] [Reference Citation Analysis]
6 Bai MY, Lovejoy DB, Guillemin GJ, Kozak R, Stone TW, Koola MM. Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders. Complex Psychiatry 2021;7:19-33. [PMID: 35141700 DOI: 10.1159/000515066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Çakmak R, Başaran E, Şentürk M. Synthesis, characterization, and biological evaluation of some novel Schiff bases as potential metabolic enzyme inhibitors. Arch Pharm (Weinheim) 2022;:e2100430. [PMID: 34994010 DOI: 10.1002/ardp.202100430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Correia BSB, Nani JV, Waladares Ricardo R, Stanisic D, Costa TBBC, Hayashi MAF, Tasic L. Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia. Biomedicines 2021;9:235. [PMID: 33652776 DOI: 10.3390/biomedicines9030235] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Gan J, Wang M, Liu S, Chen Z, Wang XD, Ji Y. Effect of Multiple Medicines on Dementia Initial Treatment: Experience and Thinking. Am J Alzheimers Dis Other Demen 2021;36:15333175211053134. [PMID: 34841902 DOI: 10.1177/15333175211053134] [Reference Citation Analysis]
10 Török N, Tanaka M, Vécsei L. Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway. Int J Mol Sci 2020;21:E9338. [PMID: 33302404 DOI: 10.3390/ijms21249338] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 18.0] [Reference Citation Analysis]